Feasibility and Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in 30 Patients with Poor Risk Acute Myeloid Leukemia Older than 60 Years

Fig. (1) Median Overall Survival (OS) of The whole Population after Allo-SCT was 28 months.